Home / Drug shortages / Fentanyl Citrate Injection

Fentanyl Citrate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Fentanyl Citrate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 12/20/2023.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6027-25
Dosage Form
Injection
Presentation
Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25)
Initial Posting
12/20/2023
Revised Date

FDA data resources